Kinled Holding
VC Fund
New York, United States
Kinled Holding is a VC fund in New York focused on Biotechnology and Health Care. Kinled was founded in 1980 to retain the investment assets of the Aisher family.In 1990, the investment focus shifted to a portfolio of early stage investments applying Kinled’s company development experience alongside the endurance and passion of family owned investments together with the strategic focus of venture capitalists.Since then,Kinled has taken 8 companies to public markets and many more to successful trade sales at significant multiples.
- Total investments:
- 144
- Last investment:
- Lead investor:
- 3%
Last updated:
For AI agents: llms.txt
Industries Kinled Holding invests in
Stages Kinled Holding invests in
Countries Kinled Holding invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $594k–$14M
- Series A
- $1.7M–$40M
Investment Focus
Industry
- Biotechnology 31 (22%)
- Health Care 28 (19%)
- Software 17 (12%)
- Financial Services 17 (12%)
- FinTech 16 (11%)
Stage
- Seed 50 (35%)
- Funding Round 27 (19%)
- Series A 26 (18%)
- Series B 8 (6%)
- Series C 2 (1%)
Country
- United Kingdom 30 (21%)
- United States 22 (15%)
- Switzerland 16 (11%)
- Germany 12 (8%)
- Austria 7 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Angelo Acquista
Founder
|
Founder | Total investments: 1 | Find email | |
|
Rupert Novis
CEO & Director
|
CEO & Director | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Esper helps build an infrastructure to support the full policymaking lifecycle in government and create a single source of truth for policy. Esper works with dozens of government agencies to streamline internal workflows and manage policymaking with ease. The company has grown to over 30 employees and raised over $14 million in funding. Esper’sclients include the New York City Police Department, Washington Department of Health and California State Treasurer’s Office. | Venture - Series Unknown / Mar 10, 2026 | ||
| Varda is a space manufacturing startup that focuses on creating products in space for terrestrial applications. They aim to manufacture things in space that benefit from low gravity. The company intends to create an infrastructure that harvests source materials for new products in-space via asteroid mining.The company was founded in 2020 byDelian Asparouhov and Trae Stephens. | Series D / Feb 17, 2026 | ||
| TAG Therapeutics is a biotechnology company that develops medicines for telomere pathologies and age-related disorders. | Seed / Jan 01, 2026 | ||
| CorneaSense is a medtech startup developing a non-invasive, eye-based sensing device that measures ocular surface hydration to enable early detection and monitoring of conditions such as dry eye disease and systemic health disorders. The technology aims to provide real-time, objective eye biomarkers for improved clinical diagnosis and patient care. | Seed / Jan 01, 2026 | ||
| Q.ANT develops photonic processors for AI and high-performance computing, utilizing light for information processing. The company also produces quantum sensors offering ultra-high magnetic field sensitivity in a compact form factor. These products aim to enable more intelligent and sustainable systems across various sectors like data centers,aerospace, and medical technology. | $72M / Series A / Jul 17, 2025 | ||
| Wayflyer is a revenue-based financing platform for e-commerce brands. It provides fast and affordable funding to help grow businesses, without any of the complications and free marketing analytics to get out of budget. The company is based in Dublin, Ireland. | $35M / Series B / Jun 23, 2025 | ||
| We automate, optimize, and enhance various operational processes. This includes tasks such as document processing, fraud detection, customer support, risk assessment, compliance monitoring, and transaction management. By integrating AI into these workflows, institutions can reduce manual effort, increase processing speed, and improve accuracy,resulting in more efficient operations and better customer experiences. | $1.1M / Seed / Dec 31, 2024 | ||
| Alloy is a telehealth company addressing the healthcare needs of women over 40. | $16M / Series A / Nov 18, 2024 | ||
| Nuuron is a neurotech startup that is developing the Memory-Pacemaker, a non-invasive photonic neurostimulation device that allows Alzheimer's sufferers to store and retrieve memories anew. | $3.8M / Seed / Oct 31, 2024 | ||
| Our mission is to substantially increase investor allocations to private markets by merging quantitative research with asset and wealth management. | Seed / Mar 01, 2024 | ||
| See all 144 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Kinled Holding invest in?
Kinled Holding invests primarily in Biotechnology, Health Care and Software startups, most often at Seed and Funding Round stage. Most of the 144 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Kinled Holding's check size?
Kinled Holding typically joins rounds of $594k–$14M at Seed and $1.7M–$40M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Kinled Holding participates in.
How do I contact Kinled Holding?
Public channels for Kinled Holding include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Kinled Holding?
The team at Kinled Holding includes Angelo Acquista (Founder) and Rupert Novis (CEO & Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
